VAERS 2021 Database www.vaers.hhs.gov

Main Page | All 2021 Deaths | Videos
VAERS Updated: 10/01/2021
** VAERS DATABASE Last updated: October 1, 2021**
PLEASE CHECK BACK SOON
Download the files above while you wait.







Manufacturers

Total Manufacturer

Incidents per State

State Total
92,076
AK1,880
AL6,345
AR4,151
AS46
AZ14,991
CA66,887
CO12,550
CT8,943
DC1,795
DE2,009
FL42,724
FM4
GA17,031
GU124
HI2,580
IA4,919
ID2,892
IL22,128
IN24,197
KS5,047
KY9,111
LA5,500
MA15,718
MD13,434
ME3,351
MH8
MI20,971
MN13,585
MO10,747
MP30
MS3,198
MT2,477
NC18,051
ND1,501
NE3,109
NH3,218
NJ20,216
NM4,218
NV4,728
NY37,667
OH20,793
OK6,692
OR9,244
PA25,607
PR2,588
QM2
RI2,163
SC7,261
SD1,282
TN10,445
TX39,890
UT4,618
VA15,980
VI67
VT1,830
WA16,071
WI12,042
WV2,571
WY926
XB5
XL1
XV2

ID: 1524971
Sex: F
Age:
State: DC

Vax Date: 03/24/2021
Onset Date: 03/24/2021
Rec V Date: 08/04/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Dysphagia, Epiglottitis

Symptoms: arm was very swollen; red; itchy; This is a spontaneous report from a contactable consumer, the patient. A 35-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP6955) via an unspecified route of administration in the arm right on 24Mar2021 (at the age of 35-year-old) as a single dose for COVID-19 immunisation. Medical history included asthma. Concomitant medications included salbutamol sulfate (PROAIR), ethinylestradiol, levonorgestrel (SRONYX) and ibuprofen (MOTRIN) all from an unknown date for an unknown indication. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the arm right on 03Mar2021 (at the age of 35-year-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 24Mar2021 the patient experienced arm was very swollen and felt like there was a knot right under the injection site for a week and it was also red and itchy. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. No therapeutic measures were taken as a result of the events. The clinical outcome of the events arm was very swollen, red and itchy was recovered on an unknown date in 2021. No follow-up attempts are needed. No further information is expected.

Other Meds: Proair; SRONYX; Motrin

Current Illness:

ID: 1524972
Sex: F
Age:
State: FL

Vax Date: 04/06/2021
Onset Date: 04/07/2021
Rec V Date: 08/04/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Anxiety, Dyspnoea

Symptoms: Swelling; Reddness darkened; This is a spontaneous report from a contactable consumer, the patient. A 63-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8455) via an unspecified route of administration in the arm left on 06Apr2021 at 16:45(at the age of 63-year-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Concomitant medications included ascorbic acid, boswellia serrata resin, chondroitin sulfate, collagen, glucosamine hydrochloride, hyaluronic acid, manganese sulfate, methylsulfonylmethane, sodium, sodium borate (OSTEO BI-FLEX), ascorbic acid, tocopheryl acetate, glutathione, riboflavin, acetylcysteine, betacarotene, copper, zinc, selenium, bioflavonoids nos (ACCUVIT) and omeprazole (PRILOSEC); all from unknown date for unknown indication. The patient had no known allergies to medications, food or other products. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6955) via an unspecified route of administration in the arm left on 16Mar2021 at 16:15 (at the age of 63-year-old) as a single dose for COVID-19 immunisation. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 07Apr2021 at 06:00 the patient experienced Swelling subsided somewhat after 12-18 hours. Redness darkened and still continues 36 hours later. The was reported that she experienced Similar reaction 35 years ago to an unknown, airborne chemical that circulated through the ventilation system in a building where she was working. Dermatologist at the time, recommended taking Benadryl. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were taken for the events and included treatment herself with Benadryl. The clinical outcome of the event swelling and redness darkened was recovering. No follow-up attempts are needed. No further information is expected.

Other Meds: Osteo bi-flex; ACCUVIT; Prilosec

Current Illness:

ID: 1524973
Sex: M
Age:
State: NC

Vax Date: 04/07/2021
Onset Date: 04/08/2021
Rec V Date: 08/04/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Chest discomfort, Dysphagia, Pain in extremity, Visual impairment

Symptoms: Severe chills and shivering; Total body aches; Fatigue; Unable to get comfortable; Headache; This is a spontaneous report from a contactable consumer, the patient. A 45-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0151) via an unspecified route of administration in the right arm on 07Apr2021 at 11:30 (at the age of 45-year-old) as a single dose for COVID-19 immunisation. Medical history was reported as none. Concomitant medications included sertraline hydrochloride (ZOLOFT) and levocetirizine dihydrochloride (XYZAL) from an unknown date, for unknown indications. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER2613) via an unspecified route of administration in the right arm on 17Mar2021 at 15:30 (at the age of 45-year-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 08Apr2021 at 02:30, the patient experienced severe chills and shivering, total body aches, fatigue, unable to get comfortable and headache. Therapeutic measures were taken as a result of the events severe chills and shivering, total body aches, fatigue, unable to get comfortable and headache and included treatment with Tylenol. The clinical outcome of the events severe chills and shivering, total body aches, fatigue, unable to get comfortable and headache were not resolved at the time of report. No follow-up attempts are needed. No further information is expected.

Other Meds: ZOLOFT; XYZAL

Current Illness:

ID: 1524974
Sex: M
Age:
State: CA

Vax Date: 04/06/2021
Onset Date: 04/08/2021
Rec V Date: 08/04/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Dizziness, Fatigue, Mobility decreased

Symptoms: painful swelling in the armpit of left arm.; painful swelling in the armpit of left arm.; muscle pain; slight fever; This is a spontaneous report from a contactable consumer, the patient. A 39-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8737) via an unspecified route of administration in the left arm on 06Apr2021 at 16:00 (at the age of 39-year-old) as a single dose for COVID-19 immunisation. Medical history included severe obesity. The patient previously took sulfates and experienced allergy to it. Concomitant medications included metoprolol (MANUFACTURER UNKNOWN), acetylsalicylic acid (BABY ASPIRIN), fish oil (MANUFACTURER UNKNOWN) and multivitamins for an unknown indication from an unknown date. The patient previously took first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNNOWN) via an unspecified route of administration in the left arm on 16Mar2021 at 18:00 (at the age of 39-year-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 07Apr2021 at 03:00, about 24 hours after the vaccination, the patient experienced muscle pain and slight fever. On 08Apr2021, in the morning at 04:00, 36 hours after the vaccination, the patient had painful swelling in the armpit of left arm and it was visibly swollen compared to the right armpit. The events resulted in doctor or other healthcare professional office/clinic visit. It was unknown whether any therapeutic measures were taken as a result of the events. The clinical outcome of the events muscle pain, slight fever and painful swelling in the armpit of left arm was not recovered at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: METOPROLOL; BABY ASPIRIN; FISH OIL

Current Illness:

ID: 1524975
Sex: F
Age:
State: PA

Vax Date: 04/06/2021
Onset Date: 04/08/2021
Rec V Date: 08/04/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site pruritus, Injection site swelling, Injection site warmth

Symptoms: Throat swollen and sore; Throat swollen and sore; Feels scratchy and hurts to swallow.; Feels scratchy and hurts to swallow.; This is a spontaneous report from a contactable consumer, the patient. A 26-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0151) via an unspecified route of administration in the right arm on 06Apr2021 at 11:30 (at the age of 26-year-old) as a single dose for COVID-19 immunisation. Medical history included lupus, fibromyalgia, occasional high blood pressure. Concomitant medications included bupropion hydrochloride (WELLBUTRIN), buspirone hydrochloride (BUSPAR), clonidine (MANUFACTURER UNKNOWN) and quetiapine fumarate (SEROQUEL) and biotin (MANUFACTURER UNKNOWN) from unknown dates for an unknown indication. The patient previously took risperidone (MANUFACTURER UNKNOWN) and experience drug allergy. Prior to vaccination, it was unknown whether the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 08Apr2021 at 03:00, the patient experienced throat swollen and sore, which occurred approximately 36 hours after the vaccine and also experienced feels scratchy and hurts to swallow. Therapeutic measures were not taken as a result of the events. The adverse events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events throat swollen, throat sore, feels scratchy and hurts to swallow was not recovered at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: WELLBUTRIN; BUSPAR; CLONIDINE; SEROQUEL; BIOTIN

Current Illness:

ID: 1524976
Sex: M
Age:
State: CO

Vax Date: 02/26/2021
Onset Date: 02/26/2021
Rec V Date: 08/04/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Chills, Confusional state, Eye inflammation, Headache, Laboratory test

Symptoms: Stiffness of neck mussels; Colon spasm; Constipation; Night sweats; Loss of appetite; Foods don't taste correct; Weight loss; Very vivid dreams; Not sleeping well/can't get enoughsleep; Balance is off; Headache; Fatigue; Tired all the time; This is a spontaneous report from a contactable consumer, the patient. A 74-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6205) via an unspecified route of administration in the arm right on 26Feb2021 at 09:30(at the age of 74-year-old) as a single dose for COVID-19 immunisation. Medical history included gallbladder removal. Concomitant medications included apixaban (ELIQUIS) from unknown date for unknown indication . The patient previously took first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN9581) via an unspecified route of administration in the arm left on 04Feb2021 at 09:30(at the age of 74-year-old) as a single dose for COVID-19 immunisation. The patient previously took Bactrim and Flagyl and experienced drug allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 26Feb2021 patient experienced Headache, Stiffness of neck mussels, Colon spasm, Constipation, Night sweats, Loss of appetite, Foods don't taste correct, Weight loss, Very vivid dreams, Fatigue, Not sleeping well, Tired all the time, can't get enough sleep. Balance is off. These symptoms still on going as of 4/8/21. On 23Mar2021, the patient underwent Nasal Swab SARS CoV-2 test and the result was Negative. Therapeutic measures included treatment with Given prescription "Hyoscyamine Sulfate 0.125 Mg for unknown event. The events didn't result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events Headache, Stiffness of neck mussels, Colon spasm, Constipation, Night sweats, Loss of appetite, Foods don't taste correct, Weight loss, Very vivid dreams, Fatigue, Not sleeping well, Tired all the time, can't get enough sleep. Balance is off were not resolved at the time of the report. No follow-up attempts are needed. No further information is expected.

Other Meds: ELIQUIS

Current Illness:

ID: 1524977
Sex: F
Age:
State: WA

Vax Date: 04/06/2021
Onset Date: 04/06/2021
Rec V Date: 08/04/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Pyrexia, White blood cell count decreased

Symptoms: Face swelling; Itchy eyes; Red flushing on face and chest; Tongue numb; Rash on arms; This is a spontaneous report from a contactable consumer, the patient. A 50-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP7533) via an unspecified route of administration in the left arm on 06Apr2021 at 15:00 (at the age of 50-year-old) as a single dose for COVID-19 immunisation. Medical history included allergic to cats. The patient did not receive any concomitant medication within two weeks prior to the vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 06Apr2021 at 15:30, the patient experienced face swelling, itchy eyes, red flushing on face and chest, tongue numb and rash on arms. It was unknown whether any therapeutic measures were taken as a result of the events. The events resulted in doctor or other healthcare professional office/clinic visits. The clinical outcome of the events face swelling, itchy eyes, red flushing on face and chest, tongue numb and rash on arms were not recovered at the time of the report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1524978
Sex: F
Age:
State: FL

Vax Date: 04/03/2021
Onset Date: 04/05/2021
Rec V Date: 08/04/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Pharyngeal swelling

Symptoms: Tremendous lower back pain.; This is a spontaneous report from a contactable consumer, the patient. A 46-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: UNKNOWN) via an unspecified route of administration in the left arm on 03Apr2021 at 09:00 (at the age of 46-years-old) as single dose for COVID-19 immunisation. The patient did not have any relevant medical history. The patient had no known allergies to medications, food or other products. The patient did not take any concomitant medications. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had been tested for COVID-19. On 05Apr2021 at 09:00, the patient experienced tremendous lower back pain. The patient underwent lab test on 19Mar2021 which included SARS-CoV-2 test (nasal swab) and the result was negative. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were taken as a result of tremendous lower back pain which included purchasing of heating pad. The clinical outcome of tremendous lower back pain was recovering. No follow-up attempts are possible; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1524979
Sex: F
Age:
State: CA

Vax Date: 04/02/2021
Onset Date: 04/02/2021
Rec V Date: 08/04/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Abdominal pain, Chills, Sleep disorder

Symptoms: Chills; Headache; Body ache; Dizziness; Nausea; Fatigue; This is a spontaneous report from a contactable consumer, the patient. A 40-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: E128734) via an unspecified route of administration in the arm left on 02Apr2021 at 13:00 (at the age of 40-year-old) as a single dose for COVID-19 immunisation. Medical history included dizziness which recovered with physical therapy and still patient felt like had a slight relapse in dizziness. Concomitant medications included vitamin B complex (B-complex), cetirizine 10 mg (MANUFACTURER UNKNOWN) and magnesium supplement (MANUFACTURER UNKNOWN) from an unknown date for an unknown indication. The patient had no allergies to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 02Apr2021 the patient experienced chills, headache, body ache, dizziness, nausea and fatigue and reported that all the symptoms lasting 6 days post-vaccine. The patient also reported that she felt better on day 3, then worse on day 4, better on day 5 and worse again on day 6. The patient did not receive any treatment for the reported events. The clinical outcome of the events chills, headache, body ache, dizziness, nausea and fatigue were not recovered at the time of the report. No follow-up attempts are needed. No further information is expected.

Other Meds: B-complex; CETIRIZINE; MAGNESIUM

Current Illness:

ID: 1524980
Sex: F
Age:
State:

Vax Date: 04/07/2021
Onset Date: 04/07/2021
Rec V Date: 08/04/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Diarrhoea, Nasal congestion

Symptoms: Symptoms of migraine; Light sensitivity; Headache; Discomfort; Difficult to focus on computer screen; This is a spontaneous report from a contactable consumer, the patient. A 36-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ew0151) via an unspecified route of administration in the right arm on 07Apr2021 at 11:30 (at the age of 36-year-old) as a single dose for COVID-19 immunisation. Medical history included mild asthma. Concomitant medications included calcium (MANUFACTURER UNKNOWN), magnesium (MANUFACTURER UNKNOWN) and vitamin D (MANUFACTURER UNKNOWN) all for unspecified indication from an unknown date. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 07Apr2021 at 17:00 the patient experienced symptoms of a migraine which the patient suffered periodically. She experienced specifically light sensitivity and headache. The light sensitivity persisted with sunlight and computer screen causing discomfort. The computer screen was difficult to focus on. The patient did not receive any treatment for the events. The events did not result in doctor or other healthcare professional office/clinic, emergency room/department or urgent care. The clinical outcome of the events symptoms of migraine, light sensitivity, headache, discomfort and difficult to focus on computer screen was not resolved at the time of report. No follow-up attempts are needed. No further information is expected.

Other Meds: CALCIUM; MAGNESIUM; VITAMIN D NOS

Current Illness:

ID: 1524981
Sex: M
Age:
State: TX

Vax Date: 04/05/2021
Onset Date: 04/05/2021
Rec V Date: 08/04/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Vaccination site erythema, Vaccination site pruritus, Vaccination site swelling

Symptoms: Rash on top of foot; Burning toes; Sore toes; Red toes; This is a spontaneous report from a contactable consumer, the patient. An 83-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8737), via an unspecified route of administration in the left arm on 05Apr2021 at 10:30 (at the age of 83-year-old), as a single dose for COVID-19 immunisation. Medical history included atrial fibrillation (Afib). The patient did not have any allergies to food, medications, or other products. The patient received other medications (unspecified) within 2 weeks of vaccination. The patient previously received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6206), via an unspecified route of administration in the left arm on 13Mar2021 at 15:15 (at the age of 83-year-old), as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 05Apr2021 at 22:00 (same day after injection), the patient woke up with burning and sore red toes. On 06Apr2021 (second day after injection), the patient woke up with sore red toes on left foot and rash on top of foot. The adverse events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the events. The clinical outcome of the events burning toes, sore toes, red toes and rash on top of foot was not resolved. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1524982
Sex: F
Age:
State: FL

Vax Date: 04/07/2021
Onset Date: 04/07/2021
Rec V Date: 08/04/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Rash, Urticaria

Symptoms: Ringing in ears; Left ear stuffiness; Migraine; Intense body aches; This is a spontaneous report from a non-contactable consumer, the patient. A 24-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER 8734) via an unspecified route of administration in the left arm on 07Apr2021 at 10:45 (at the age of 24-year-old) as a single dose for COVID-19 immunisation. Medical history included chronic fatigue, fibromyalgia and dysautonomia. The patient previously received penicillin for an unknown indication on an unknown date and experienced allergy. Concomitant medications included bupropion hydrochloride (WELLBUTRIN), escitalopram oxalate (LEXAPRO) and famotidine (PEPCID AC); all from unknown dates for unknown indications. Prior to the vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 07Apr2021 at 13:15, the patient experienced ringing in ears, left ear stiffness, migraine and intense body aches. The patient did not receive any treatment for the reported events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events of ringing in ears, left ear stiffness, migraine and intense body aches were not recovered at the time of reporting. No follow-up attempts are possible. No further information is expected.

Other Meds: WELLBUTRIN; LEXAPRO; PEPCID AC

Current Illness:

ID: 1524983
Sex: F
Age:
State:

Vax Date: 04/05/2021
Onset Date: 04/05/2021
Rec V Date: 08/04/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Blood pressure decreased, Chest pain, Chills, Confusional state, Decreased appetite

Symptoms: Sleepy; Pain at the injection site; This is a spontaneous report from a non-contactable consumer. A non-pregnant female patient of an unknown age received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on 05Apr2021 as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. Prior to vaccination, it was unknown whether the patient was diagnosed with COVID-19. Since the vaccination, it was unknown whether the patient had been tested for COVID-19. On 05Apr2021, around 3 hours after the vaccination, the patient became sleepy, the feeling of sleepiness persisted until the next morning and the patient also experienced with some pain at the injection site. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. It was unknown whether therapeutic measures were taken as a result of the events. The clinical outcome of sleepy and pain at the injection site was recovered on an unknown date in Apr2021. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds:

Current Illness:

ID: 1524984
Sex: F
Age:
State: FL

Vax Date: 02/03/2021
Onset Date: 02/15/2021
Rec V Date: 08/04/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Dyspnoea, Fatigue, Feeling abnormal, Head discomfort, Headache

Symptoms: Tinnitus both ears; This is a spontaneous report from a contactable consumer, the patient. A 71-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: El9263) via an unspecified route of administration in the left arm on 03Feb2021 (at the age of 71-years-old) as a single dose for COVID-19 immunisation. Medical history included fibromyalgia. The patient had history of known allergies to penicillin (MANUFACTURER UNKNOWN). Concomitant medications included rosuvastatin calcium (CRESTOR), amitriptyline hydrochloride, chlordiazepoxide hydrochloride (LIMBITROL), losartan (MANUFACTURER UNKNOWN) and esomeprazole magnesium (NEXIUM); all from an unknown date for unknown indication. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EI1284) via an unspecified route of administration in the left arm on 13Jan2021 at 10:00 as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other medications or vaccines within 4 weeks prior to the COVID vaccine. On 15Feb2021, the patient experienced tinnitus both ears. The event resulted in doctor or other healthcare professional office/clinic visit. No therapeutic measures were taken as a result of the reported event. The clinical outcome of tinnitus both ears was not recovered. No follow-up attempts are needed. No further information is expected.

Other Meds: CRESTOR; Limbitrol; LOSARTAN; Nexium

Current Illness:

ID: 1524985
Sex: F
Age:
State: TX

Vax Date: 04/08/2021
Onset Date: 04/08/2021
Rec V Date: 08/04/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Heart rate decreased, Heart rate increased, Hypertension, Injection site pain, Musculoskeletal chest pain

Symptoms: Metallic taste immediately after.; This is a spontaneous report from a contactable consumer, the patient. A 45-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8727) via an unspecified route of administration in the arm right on 08Apr2021 at 11:45 (at the age of 45-year-old) as a single dose for COVID-19 immunisation. Medical history included asthma, allergies, CVID immune deficiency and ehlers-danlos syndrome. Concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 08Apr2021 at 11:45, the patient experienced metallic taste immediately after. The event did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. No therapeutic measures were taken as a result of the event. The clinical outcome of the event metallic taste immediately after was not recovered at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1524986
Sex: F
Age:
State:

Vax Date: 04/06/2021
Onset Date: 04/01/2021
Rec V Date: 08/04/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Nausea, Pain, Pain in extremity, Paraesthesia oral, Pyrexia

Symptoms: Aches; Increased hunger; Fatigue; Some diarrhea; Dizzy; Lightheadedness; This is a spontaneous report from a contactable consumer, the patient. A 31-year-old, non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EW0150) via an unspecified route in left arm on 06Apr2021 (at the age of 31-year-old) as single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient was not tested for COVID-19. The patient did not receive any other vaccination within 4 weeks prior to the COVID vaccine. On 06Apr2021 at 17:00 hours, the patient had fatigue, aches, increased hunger, some diarrhea and after first 24 hours these subsided. On an unknown date in Apr2021, the patient experienced light headedness and dizzy. The patient did not receive any treatment for the events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events of fatigue, aches, increased hunger, some diarrhea were recovered on 07Apr2021; while that of light headedness and dizzy was unknown at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1524987
Sex: F
Age:
State: WA

Vax Date: 04/02/2021
Onset Date: 04/03/2021
Rec V Date: 08/04/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: SARS-CoV-2 antibody test, SARS-CoV-2 test negative

Symptoms: full blown head/sinus; chills; tiredness; feeling that throat was scratchy; little tired the following day after the 2nd dose.; This is a spontaneous report from a contactable consumer, the patient. A 67-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 02Apr2021 at 16:00 (at the age of 67-years-old) as a single dose for COVID-19 immunisation. Medical history included penicillin allergy, milk allergy and sulfonamide allergy. The patient did not receive any medication within two weeks of vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 03Apr2021, the patient experienced a little tired the following day after the 2nd dose. On 05Apr2021 at 16:00, the patient experienced feeling that throat was scratchy. On 6Apr2021, experienced full-blown head/sinus cold accompanied by chills and tiredness with no fever. Patient did not receive any treatment for the events. The clinical outcome of the events tiredness, itchy throat, sinusitis, cold, chills was resolving at the time of reporting. No follow-up attempts are needed; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1524988
Sex: F
Age:
State: CA

Vax Date: 04/06/2021
Onset Date: 04/07/2021
Rec V Date: 08/04/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Ear pain, Hypoaesthesia

Symptoms: Body aches; fever; chills; Swollen lymph nodes; This is a spontaneous report from a contactable consumer, the patient. A 41-year-old non-pregnant female patient received the unknown dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: EN6208 & ER8737), via an unspecified route of administration in the left arm on 06Apr2021 at 14:30 (at the age of 41-years-old) as a single dose for COVID-19 immunisation. Medical history included hypothyroidism. The patient was allergic to gluten and latex. Concomitant medications included levothyroxine sodium (SYNTHROID) for an unknown indication from an unknown date. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 07Apr2021 at 20:00, the patient experienced body aches, fever, chills (which the patient expected) and swollen lymph nodes. No therapeutic measures were taken as a result of the adverse events. The adverse event did not result in a visit to the doctor or other healthcare professional office/clinic visit, and the emergency room/department or urgent care. The clinical outcomes of the events body aches, fever, chills (which was she expected) and swollen lymph nodes were not recovered at the time of the report. No follow-up attempts are needed. No further information is expected.

Other Meds: SYNTHROID

Current Illness:

ID: 1524989
Sex: U
Age:
State: WI

Vax Date: 03/31/2021
Onset Date: 03/31/2021
Rec V Date: 08/04/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Abdominal pain upper, Dizziness, Dysgeusia

Symptoms: Achy; Nausea; hot and cold, 99temp at times; Bumps and burning in my mouth; Bumps and burning in my mouth; Ears ringing; Large bruise at injection sight.; This is a spontaneous report from a contactable consumer, the patient. A 64-year-old unknown gender patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Ew0150) via an unspecified route of administration in the left arm on 31Mar2021 at 11:00 (at the age of 64-year-old) as a single dose for COVID-19 immunisation. Medical history included pancreatitis. The patient received unspecified medication within two weeks of vaccination. The patient previously took Atropine on unknown date for unspecified indication and experienced drug allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 31Mar2021 at 13:00 the patient experienced achy, nausea, hot and cold, 99temp at times, bumps and burning in mouth, ears ringing and large bruise at injection sight. Bruised lasted still after 1 week. On 31Mar2021, the patient underwent lad test and procedures, which included body temperature and the result was 99temp. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the reported event. The clinical outcome of the events achy, nausea, hot and cold, bumps and burning in mouth, ringing ears and bruise at injection site was not recovered. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1524990
Sex: F
Age:
State:

Vax Date: 04/08/2021
Onset Date: 04/08/2021
Rec V Date: 08/04/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Blood pressure increased, Chest discomfort, Heart rate increased

Symptoms: Dizziness; Foggy brain; This is a spontaneous report from a non-contactable consumer, the patient. A 33-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 08Apr2021 at 11:00 (at the age of 33-years-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. Patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 08Apr2021 at 12:15 the patient experienced dizziness, foggy brain. The patient did not receive any treatment for the events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events dizziness, foggy brain was resolving. No follow-up attempts are possible; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1524991
Sex: F
Age:
State: NY

Vax Date: 04/07/2021
Onset Date: 04/08/2021
Rec V Date: 08/04/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site pruritus, Injection site swelling, Lymph node pain, Lymphadenopathy

Symptoms: Sore arm; Fatigue; Chills; Nausea; This is a spontaneous report from a contactable consumer, the patient. A 33-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP6955), via an unspecified route of administration in the left arm on 07Apr2021 at 15:45 (at the age of 33-years-old) as a single dose for COVID-19 immunisation. The patient had not reported any other health issue. The patient had no known allergies to medications, food or other products. The patient did not receive any medication within two weeks of the COVID-19 vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EP6955), via an unspecified route of administration in the left arm on 17Mar2021 at 14:30 (at the age of 32-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccination. On 08Apr2021 at 08:00, the patient experienced sore arm, fatigue, chills and nausea. The events did not result in a doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events sore arm, fatigue, chills and nausea. The clinical outcome of the events sore arm, fatigue, chills and nausea were resolving at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1524992
Sex: M
Age:
State: NJ

Vax Date: 03/29/2021
Onset Date: 03/30/2021
Rec V Date: 08/04/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Unevaluable event

Symptoms: Heavy pressure on both ears, seems as if there is heavy suction placed on both ears; Sound seems to be muffled; Extreme difficulty in sleeping; Right ear starts ringing; Difficulty with concentration; Difficulty with hearing; Rising stress; Rising stress and anxiety.; This is a spontaneous report from a contactable consumer, the patient. A 33-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ERB733) via an unspecified route of administration in the left arm on 29Mar2021 at 17:00 (at the age of 33-years-old) as a single dose for COVID-19 immunisation. Medical history included allergy to apple skins. The patient did not receive any concomitant medications. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 30Mar2021, Tuesday morning, the patient's right ear started ringing. It happened again in succession less than 10 minutes apart. Wednesday evening, right ear rings again, twice in succession less than 10 minutes apart. Thursday morning, after awaking, left ear started to ring, similar to the right ear the days prior. By Thursday night, on 01Apr2021, the patient experienced constant ringing inside head, extreme difficulty in sleeping and sound seemed to be muffled. By Friday, on 02Apr2021, the patient experienced heavy pressure on both ears, seemed as if there was heavy suction placed on both ears. On Saturday, 03Apr2021, the patient visited local Urgent Care Clinic and was diagnosed with tinnitus-bilateral. On 07Apr2021, the patient visited an ENT and was diagnosed/confirmed with tinnitus. On an unknown date in 2021, the patient experienced difficulty with concentration, hearing, rising stress and anxiety. The events had resulted in doctor or other healthcare professional office/clinic visit and emergency room/department visit or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events right ear started ringing, extreme difficulty in sleeping, sound seems to be muffled, heavy pressure on both ears, seemed as if there is heavy suction placed on both ears, difficulty with concentration, hearing, rising stress and anxiety was not recovered at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1524993
Sex: M
Age:
State: CA

Vax Date: 03/24/2021
Onset Date: 03/27/2021
Rec V Date: 08/04/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Chills, Dizziness, Injection site pain, Myalgia, Pyrexia

Symptoms: full ache at the site of the shot; prickly sensations in hand and finger tips; left harm has gone numb randomly three times; This is a spontaneous report from a contactable consumer, the patient. A 33-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP6955) via an unspecified route of administration in the left arm on 24Mar2021 at 09:45 (at the age of 33-year-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 27Mar2021, the patient experienced numbness of upper arm. On 31Mar2021, the patient experienced prickling of hand. On 08Apr2021, the patient experienced vaccination site pain. Its reported that his left arm had gone numb randomly three times since the vaccine. The first time was while sleeping about 3 days following shot. He was not sleeping on the arm at the time and could find no logical explanation for the sudden numbness. The second time was while driving home 7 days following the shot. His arm suddenly went numb and had prickly sensations in hand and finger tips. The third time was 08Apr2021, 15 days following shot. The numbness was sudden and went away within 60 seconds but the prickly had persisted. There was also a full ache at the site of the shot. The patient did not receive any treatment for the reported events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the event of numbness of upper arm was recovered with sequelae on an unknown date in Apr2021 while the clinical outcome of the event of prickling of hand was not recovered at the time of this report and the clinical outcome of the event of vaccination site pain was unknown at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1524994
Sex: M
Age:
State: CA

Vax Date: 04/06/2021
Onset Date: 04/07/2021
Rec V Date: 08/04/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Injection site pain, Pain

Symptoms: Fluid filled bubble right at the injection site; This is a spontaneous report from a contactable consumer, the patient. A 40-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8737) via an unspecified route of administration in the left arm on 06Apr2021 at 13:30 (at the age of 40-year-old) as a single dose for COVID-19 immunisation. Medical history included type 1 diabetes mellitus. The patient did not have any allergies to food, medications, or other products. Concomitant medications included insulin lispro (HUMALOG) and atorvastatin (MANUFACTURER UNKNOWN); all from an unknown date for an unknown indication. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Erz613) via an unspecified route of administration in the right arm on 16Mar2021 at 15:30 (at the age of 39-year-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 07Apr2021 at 16:00, the patient developed a fluid filled bubble right at the injection site of the second dose. Two days later, it was still there. No therapeutic measures were taken as a result of the event. The clinical outcome of the event fluid filled bubble right at the injection site was not resolved at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: HUMALOG; ATORVASTATIN

Current Illness:

ID: 1524995
Sex: F
Age:
State: TN

Vax Date: 04/08/2021
Onset Date: 04/01/2021
Rec V Date: 08/04/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Injection site pain, Menorrhagia

Symptoms: Rapid heartbeat; Nausea; Fever; Extreme pain in arm; Painful swelling under arm/breast and in neck; Burning feeling in arm; This is a spontaneous report from a contactable consumer, the patient. A 47-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8734) via an unspecified route of administration in the left arm on 08Apr2021 at 08:30 (at the age of 47-years-old) as a single dose for COVID-19 immunisation. Medical history included COVID-19 on an unknown date. The patient had no known allergies to medications, food, or other products. Concomitant medications included valuation (MANUFACTURER UNKNOWN), omeprazole (MANUFACTURER UNKNOWN), metformin (MANUFACTURER UNKNOWN) and furosemide (MANUFACTURER UNKNOWN); all from unknown dates for unknown indications. Prior to the vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On an unknown date in Apr2021, the patient experienced rapid heartbeat, nausea, fever, extreme pain/burning feeling in arm and painful swelling under arm/breast and in neck. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events rapid heartbeat, nausea, fever, extreme pain/burning feeling in arm and painful swelling under arm/breast and in neck was not recovered at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: OMEPRAZOLE; METFORMIN; FUROSEMIDE

Current Illness:

ID: 1524996
Sex: F
Age:
State: FL

Vax Date: 03/31/2021
Onset Date: 04/03/2021
Rec V Date: 08/04/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Arthralgia, Chills, Headache, Mobility decreased, Myalgia

Symptoms: Lump on my upper right arm at injection site.; This is a spontaneous report from a contactable consumer, the patient. A 76-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number: EP7534), via an unspecified route of administration in the right arm on 31Mar2021 at 11:00 (at the age of 76-years-old) as a single dose for COVID-19 immunisation. Medical history included diabetes and sulfa (sulfonamide) allergy. The patient received unspecified medications within two weeks of the vaccination. The patient previously received codeine and experienced a drug allergy. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number: EN6199), via an unspecified route of administration in the right arm on 10Mar2021 at 11:00 (at the age of 76-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccination. On 03Apr2021 at 11:00, the patient experienced a lump on her upper right arm at injection site. The event did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the event lump on the upper right arm at injection site. The clinical outcome of the event lump on upper right arm at injection site was not resolved at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1524997
Sex: F
Age:
State: IA

Vax Date: 04/02/2021
Onset Date: 04/02/2021
Rec V Date: 08/04/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Nausea, Pain in extremity, Pyrexia

Symptoms: Chills; body aches; fever; Tired; This is a spontaneous report from a contactable consumer, the patient. A 61-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8732) via an unspecified route of administration in the left arm on 02Apr2021 at 11:00 (at the age of 61-year-old) as a single dose for COVID-19 immunisation. Medical history included hypertension. Concomitant medications included irbesartan (MANUFACTURER UNKNOWN) and fexofenadine hydrochloride (ALLEGRA), both from unknown dates for unknown indications and unknown if ongoing. The patient had no known allergies to medications, food or other products. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW6215) via an unspecified route of administration in the left arm on 10Mar2021 at 11:45 (at the age of 60-year-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 02Apr2021 at 20:30, on the evening of second vaccine, the patient was tired. On 03Apr2021 at 01:30, the patient experienced chills, body aches and fever and it lasted until the evening of 04Apr2021. On 05Apr2021 the patient was still tired and on 06Apr2021 she was better. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. No therapeutic measures were taken for the reported events. The clinical outcome of the events chills, body aches and fever was resolved on the evening of 04Apr2021 and the event tired was recovered on an unknown date in Apr2021. No follow-up attempts are needed. No further information is expected.

Other Meds: IRBESARTAN; ALLEGRA

Current Illness:

ID: 1524998
Sex: F
Age:
State: PA

Vax Date: 04/02/2021
Onset Date: 04/05/2021
Rec V Date: 08/04/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Chills, Fatigue, Headache, Myalgia

Symptoms: Fatigue; Mild headaches; stomach unsettling; unable to eat normal meals; This is a spontaneous report from a contactable consumer, the patient. A 61-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the arm left on 02Apr2021 at 11:00 (at the age of 61-year-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient was not tested for COVID-19. The patient did not receive any vaccination within four weeks prior to the COVID-19 vaccine. On 05Apr2021, the patient experienced fatigue, mild headaches, stomach unsettling and unable to eat normal meals. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the events. The clinical outcome of the events fatigue, mild headaches, stomach unsettling and unable to eat normal meals was not recovered. No follow-up attempts are needed; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1524999
Sex: M
Age:
State: MN

Vax Date: 04/07/2021
Onset Date: 04/07/2021
Rec V Date: 08/04/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Headache, Heart rate increased, Injection site erythema, Injection site pain, Injection site swelling

Symptoms: Headache; stiff neck; dry mouth; moderate injection site pain; This is a spontaneous report from a contactable consumer, the patient. A 62-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Ew01vz) via an unspecified route of administration in the right arm on 07Apr2021 at 10:15 (at the age of 62-year-old) as a single dose for COVID-19 immunisation. The patient previously took the first dose BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Er8727) via an unspecified route of administration in the left arm on 17Mar2021 at 10:30 (at the age of 62-year-old) as a single dose for COVID-19 immunisation. Medical history included subacute small fiber sensory neuropathy and partial paralysis. Patient previously received penicillin for an unknown indication on an unknown date and experienced drug allergy. Concomitant medication included pregabalin (MANUFACTURER UNKNOWN) for an unknown indication from an unknown date. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 07Apr2021 at 10:45, the patient had headache, stiff neck, dry mouth and moderate injection site pain. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the events. The clinical outcome of the events of headache, stiff neck, dry mouth and moderate injection site pain was recovering at the time of this report. No follow-up attempts are possible. No further information is expected.

Other Meds: PREGABALIN

Current Illness:

ID: 1525000
Sex: F
Age:
State: CO

Vax Date: 04/06/2021
Onset Date: 04/06/2021
Rec V Date: 08/04/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Nausea

Symptoms: Pins and needles; Prickling over entire body; All over body itching; This is a spontaneous report from a contactable consumer, the patient. A 45-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN), via an unspecified route of administration in the left arm on 06Apr2021 at 16:30 (at the age of 45-year-old), as a single dose for COVID-19 immunisation. Medical history included crohn's disease, inflammatory arthritis and fibromyalgia. Concomitant medications included hydroxychloroquine (MANUFACTURER UNKNOWN) on an unknown date for unknown indication, BENADRYL on an unknown date for unknown indication, vitamin (MANUFACTURER UNKNOWN) on an unknown date for unknown indication and TYLENOL on an unknown date for unknown indication. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 06Apr2021 at 20:00, the patient experienced all over body itching, pins and needles, prickling over entire body at once for two days so far. The patient went to sleep itching and wake up itching under skin, like thousands of little bugs crawling under skin. Started about four hours after injection. Therapeutic measures were taken as a result of events and included treatment with tylenol, benadryl, and 20 mg prednisone on an unknown date. The adverse event resulted in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events prickling over entire body, body itching, pins and needles was not resolved. No follow-up attempts are needed; Information regarding lot number cannot be obtained. No further information is expected.

Other Meds: HYDROXYCHLOROQUINE SULFATE; BENADRYL; TYLENOL

Current Illness:

ID: 1525001
Sex: F
Age:
State: MD

Vax Date: 03/25/2021
Onset Date: 03/27/2021
Rec V Date: 08/04/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Injection site pain

Symptoms: Enlarged lymph gland on right side of neck; swelling and pain under chin; mandible to right ear; This is a spontaneous report from a contactable consumer, the patient. A 73-year-old non-pregnant female patient received unknown dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, lot number: BV02123480) via an unspecified route of administration in the left arm on 25Mar2021 at 11:30 as a single dose for COVID-19 immunisation. Medical history included hypothyroidism, parathyroid disorder, sarcoidosis and gout. The patient had no known allergies to food, medications or other products. Concomitant medications included levothyroxine sodium (SYNTHROID, 125 unspecified units) azilsartan medoxomil, chlortalidone (EDARBYCLOR, 40 unspecified units) for unknown indication from unknown date and unknown if ongoing. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 27Mar2021 at 08:00, third day after the vaccination in the left arm, the patient experienced enlarged lymph gland on right side of neck, swelling and pain under chin and mandible to right ear. The event resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of AEs and included treatment with CT scan with contrast and Clindamycin. On 29Mar2021, the patient underwent CT scan with contrast and the result was Level 2 lymph node near tail of right parotid 12 x21mm x 19mm per CT of soft tissue neck with contrast. The clinical outcome of the event enlarged lymph gland on right side of neck, swelling and pain under chin and mandible to right ear was recovering at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: SYNTHROID; EDARBYCLOR

Current Illness:

ID: 1525002
Sex: F
Age:
State: MT

Vax Date: 04/07/2021
Onset Date: 04/08/2021
Rec V Date: 08/04/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Injection site induration, Injection site pruritus, Injection site swelling, Injection site warmth

Symptoms: Eyes were nearly swollen shut; This is a spontaneous report from a contactable consumer, the patient. A 23-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number: EP7533) via an unspecified route of administration in the left arm on 07Apr2021 at 13:00 (at the age of 23-year-old) as a single dose for COVID-19 immunisation. The patient had no medical history. Concomitant medications included ethinylestradiol, norgestimate (TRI-SPRINTEC) on unknown date for birth control. The patient had no known allergies to medications, food or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 08Apr2021 at 06:00 the patient experienced eyes were nearly swollen shut .The event resulted in doctor or other healthcare professional office/clinic visit. The patient did not receive any treatment for the event. The clinical outcome of the event eyes were nearly swollen shut was not recovered. No follow-up attempts are needed. No further information is expected.

Other Meds: TRI-SPRINTEC

Current Illness:

ID: 1525003
Sex: M
Age:
State: LA

Vax Date: 04/03/2021
Onset Date: 04/04/2021
Rec V Date: 08/04/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Chills, Dizziness, Nausea, Pain, Tachycardia

Symptoms: nausea; Severe headache; This is a spontaneous report from a non-contactable consumer, the patient. A 64-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN), via an unspecified route of administration in the right arm on 03Apr2021 at 11:15 (at the age of 64-year-old), as a single dose for COVID-19 immunisation. Medical history was not reported. Concomitant medications included metformin (MANUFACTURER UNKNOWN) glibenclamide (GLYBURIDE) losartan (MANUFACTURER UNKNOWN) amlodipine (MANUFACTURER UNKNOWN) and escitalopram oxalate (CITALO) all were from unknown date and for unspecified indication. The patient previously took first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN), via an unspecified route of administration on an unspecified date as a single dose for COVID-19 immunisation. The patient had reported no known allergies. Prior to the vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 04Apr2021, the patient experienced severe headache and nausea. The adverse event resulted in doctor or other healthcare professional office/clinic visit and in emergency room/department or urgent care. The patient underwent CT scan of head, blood work, on an unknown date and the results of the test were not reported. Therapeutic measures were taken as a result of adverse events and included treatment with reglan, benadryl and morphine. The clinical outcome of the events severe headache and nausea was not resolved. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds: METFORMIN; GLYBURIDE; LOSARTAN; AMLODIPINE; Citalo

Current Illness:

ID: 1525004
Sex: F
Age:
State: FL

Vax Date: 04/07/2021
Onset Date: 04/07/2021
Rec V Date: 08/04/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Tremor

Symptoms: Rapid Heartrate; This is a spontaneous report from a contactable consumer, the patient. A 62-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0151) via an unspecified route of administration in the left arm on 07Apr2021 at 13:30 (at the age of 62-years-old) as a single dose for COVID-19 immunisation. Medical history included penicillin allergy. Concomitant medications included ascorbic acid; calcium; minerals nos; retinol; tocopheryl acetate; vitamin b nos; vitamins nos; zinc (CENTRUM SILVER) from an unknown date for an unspecified indication. The patient previously took first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Unknown) via an unspecified route of administration on an unknown date as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 07Apr2021 at 15:15, the patient experienced rapid Heartrate regular heartrate. About 10 times heartrate would return to normal for about 2 minutes then start the fast rate again. The patient did not receive any treatment for the event. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the event heart rate increased was recovered on 07Apr2021 at 1800. No follow-up attempts are needed. No further information is expected.

Other Meds: Centrum silver

Current Illness: Penicillin allergy

ID: 1525005
Sex: F
Age:
State: MA

Vax Date: 03/21/2021
Onset Date: 03/24/2021
Rec V Date: 08/04/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Erythema, Pruritus

Symptoms: Rash on body (diagnosed as pityriasis rosea by doctor) which spread to other areas; fatigue; chills; sneezing; This is a spontaneous report from a contactable consumer, the patient. A 29-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER 2613) via an unspecified route of administration in the left arm on 21Mar2021 at 12:15 (at the age of 29-years-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medication were not reported. The patient had no known allergies to medications, food or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 24Mar2021, the patient experienced rash on body (diagnosed as pityriasis rosea by doctor) which spread to other areas, fatigue, chill and sneezing. The events pityriasis rosea, fatigue, chills and sneezing resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of pityriasis rosea, fatigue, chills and sneezing and included treatment with Valtrax. The clinical outcome of the events pityriasis rosea, fatigue, chills and sneezing was not resolved at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1525006
Sex: F
Age:
State: KS

Vax Date: 04/06/2021
Onset Date: 04/07/2021
Rec V Date: 08/04/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site induration, Injection site pruritus, Injection site swelling, Myalgia

Symptoms: Muscle cramps; Pain in lower back moved to buttocks; Fatigue; Diarrhea; Back ache; Fogginess in head; Stiff neck; Felt like a fever; This is a spontaneous report from a contactable consumer, the patient. A 54-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the arm left on 06Apr2021 at 14:15 (at the age of 54-year-old) as a single dose for COVID-19 immunisation. Medical history included asthma, restless legs syndrome, penicillin allergy and anxiety. Concomitant medications included gabapentin (MANUFACTURER UNKNOWN), sleeping aid (MANUFACTURER UNKNOWN) and fluoxetine hydrochloride (PROZAC) all for unknown indication from an unknown date. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 07Apr2021 at 08:00,Next morning fatigue, diarrhea, back ache, stiff neck, fogginess in head. Felt like she had a fever. Better by evening. On 08Apr2021, 2nd morning after shot, woke up feeling even worse - severe back pain, fogginess in head, fatigue, diarrhea again. Pain in lower back moved to buttocks - muscle cramps. No therapeutic measures were taken as a result of the events. The events did not result in doctor or other healthcare professional office or clinic visit, and emergency room or department or urgent care. The clinical outcome of the events fatigue, diarrhea, back ache, stiff neck, fogginess in head, felt like a fever, muscle cramps and pain in buttocks were resolving at the time of this report No follow-up attempts are possible; information about lot/batch number cannot be obtained.

Other Meds: GABAPENTIN; PROZAC

Current Illness:

ID: 1525007
Sex: F
Age:
State: NV

Vax Date: 02/23/2021
Onset Date: 03/01/2021
Rec V Date: 08/04/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Cough, Limb discomfort, Pain, SARS-CoV-2 test positive

Symptoms: Erythema nodosum: painful, redlumps on lower legs, shin and kneearea; Erythema nodosum: painful, red lumps on lower legs, shin and knee area. Increasing in size and limiting mobility until beginning steroid treatment with primary physician; This is a spontaneous report from a contactable consumer, the patient. A 59-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6200) via an unspecified route of administration in the left arm on 23Feb2021(at the age of 59-year-old) as a single dose for COVID-19 immunisation. Medical history included asthma, arthritis, allergy and penicillin allergy. The patient previously took vancomycin and experienced allergy to it. Concomitant medications included cetirizine hydrochloride (ZYRTEC), triamcinolone acetonide (NASACORT) and omeprazole (MANUFACTURER UNKNOWN). Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 01Mar2021, the patient experienced erythema nodosum (painful, red lumps on lower legs, shin and knee area) which was increasing in size and limiting mobility. The event resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of adverse events and included treatment with oral steroids. The clinical outcome of the events erythema nodosum (painful, red lumps on lower legs, shin and knee area) which is increasing in size and limiting mobility was recovering at the time of this report. No follow-up attempts are possible. No further information is expected.

Other Meds: Zyrtec; NASACORT; OMEPRAZOLE

Current Illness:

ID: 1525008
Sex: M
Age:
State: WA

Vax Date: 02/20/2021
Onset Date: 02/22/2021
Rec V Date: 08/04/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Asthenia, Chills, Headache, Myalgia

Symptoms: Hives on arms and legs; This is a spontaneous report from a contactable consumer, the patient. A 67-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6198) via an unspecified route of administration in the left arm on 20Feb2021 at 11:00 (at the age of 67-years-old) as a single dose for COVID-19 immunisation. Medical history included High Blood Pressure (HBP), Benign Prostatic Hyperplasia (BPH) and allergy to sulfa-based antibiotics. Concomitant medications included metoprolol (MANUFACTURER UNKNOWN), doxazosin mesilate (CARDURA) and doxazosin (MANUFACTURER UNKNOWN), all taken from unknown dates for unspecified indications. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EL9262) via an unspecified route of administration in the left arm on 30Jan2021 at 10:45 (at the age of 67-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 22Feb2021, two days after the second vaccination, the patient experienced hives on arms and legs, some of these were quite large (larger than a 50 cent coin). The event did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the event. The clinical outcome of the event hives on arms and legs was resolved on 27Feb2021. No follow-up attempts are needed. No further information is expected.

Other Meds: METOPROLOL; CARDURA; DOXAZOSIN

Current Illness:

ID: 1525009
Sex: M
Age:
State: VA

Vax Date: 03/29/2021
Onset Date: 04/06/2021
Rec V Date: 08/04/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site pain, Injection site swelling

Symptoms: burning primarily on feet and hands; Itching primarily on feet and hands; Hives primarily on feet and hands; This is a spontaneous report from a contactable other- healthcare professional, the patient. A 52-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 29Mar2021 at 13:30 (at the age of 52-years-old) as a single dose for COVID-19 immunisation. Medical history included graves disease, blood pressure high (HBP) and overweight. The patient received other unspecified medications within two weeks of the vaccination. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously received penicillin and levofloxacin (LEVOQUIN) and experienced allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. On 06Apr2021 at 13:00, the patient broke out in burning and itching hives primarily on feet and hands. The events resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of events which included treatment with MEDROL dose pack. The clinical outcome of the events broke out in burning and itching hives primarily on feet and hands were not resolved at the time of this report. No follow-up attempts are needed; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1525010
Sex: F
Age:
State: FL

Vax Date: 03/30/2021
Onset Date: 03/31/2021
Rec V Date: 08/04/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Chills, Feeling cold, Feeling hot, Myalgia, Pain

Symptoms: Hives all over body that started on my face, neck andshoulders and spread down my body over; Get irritated; This is a spontaneous report from a contactable consumer, the patient. A 47-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Unknown) via an unspecified route of administration in the left arm on 30Mar2021 at 17:00 (at the age of 47-years-old) as a single dose for COVID-19 immunisation. Medical history included basal cell skin cancer and was going through radiation treatments at the time of reporting. The patient had no known allergies to medications, food or other products. The patient did not take any concomitant medications. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 31Mar2021, the patient experienced hives all over body that started on face, neck and shoulders and spread down the body over the next few days, they were not extremely itchy but those in close contact with hair or tight clothing to get irritated. The event resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of hives which included treatment with diphenhydramine (BENADRYL), cimetidine (TAGAMET) and cortisone (MANUFACTURER UNKNOWN) cream. The clinical outcomes of hives all over body and got irritated were not recovered. No follow-up attempts are needed; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1525011
Sex: F
Age:
State: CO

Vax Date: 03/25/2021
Onset Date: 03/26/2021
Rec V Date: 08/04/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Pain in extremity

Symptoms: About 28 hours post dose 2 headache; Fever chills; Malaise; This is a spontaneous report from a contactable consumer, the patient. A 51-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Ep6955) via an unspecified route of administration in the right arm on 25Mar2021 at 12:00 (at the age of 51-year-old) as a single dose for COVID-19 immunisation. The patient has not reported any other health issues. The patient did not have allergies to medications, food, or other products. The patient did not receive any other medications within two weeks of vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: El3248) via an unspecified route of administration in the right arm on 04Mar2021 at 12:30 (at the age of 51-year-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 26Mar2021 at 16:00, about 28 hours post second dose of vaccination the patient experienced headache, fever chills and malaise. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were taken as a result of adverse events and included treatment with TYLENOL. The clinical outcome of the event headache, fever chills and malaise were recovered on unknown date in 2021. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1525012
Sex: M
Age:
State: CA

Vax Date: 03/24/2021
Onset Date: 03/25/2021
Rec V Date: 08/04/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Abdominal pain upper, Abnormal behaviour, Adverse reaction, Anger, Asthma

Symptoms: 3 Days after vaccination ligament in my left shoulder tear during normal arm use.; Next day my face was swollen.; This is a spontaneous report from a contactable consumer, the patient. A 57-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN7534) via an unspecified route of administration in the left arm on 24Mar2021 at 13:30 (at the age of 57-year-old) as a single dose for COVID-19 immunisation. Concomitant medications included atenolol (MANUFACTURER UNKNOWN) for an unknown indication, from unknown date. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 25Mar2021, the patient's face was swollen. On 27Mar2021, 3 Days after vaccination the patient experienced ligament in his left shoulder tear during normal arm use. Therapeutic measures were taken as a result of both adverse events and included treatment with pain medications. The events resulted in doctor or other healthcare professional office/clinic visit. The clinical outcome of the events face was swollen and ligament in his left shoulder tear during normal arm use was not recovered at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: ATENOLOL

Current Illness:

ID: 1525013
Sex: F
Age:
State: MI

Vax Date: 04/03/2021
Onset Date: 04/03/2021
Rec V Date: 08/04/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Consciousness fluctuating, Crying, Dry skin, Epistaxis, Headache

Symptoms: sores in mouth, tongue and throat; chills; skin rash; blisters on back; skin rash on face and forehead that feels like burning and itchy; skin rash on face and forehead that feels like burning and itchy; sores in mouth, tongue and throat; sores in mouth, tongue and throat; This is a spontaneous report from a contactable consumer, the patient. A 59-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ew0150) via an unspecified route of administration in the arm left on 03Apr2021 at 8:00 (at the age of 59-year-old) as a single dose for COVID-19 immunisation. Medical history included high cholesterol. Concomitant medications included vitamins (MANUFACTURER UNKNOWN) indicated for unknown indication. The patient had a history of drug allergy to Keflex, penicillin and Bactrim. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 03Apr2021 at 18:00, the patient experienced skin rash and blisters on back, skin rash on face and forehead that feels like burning and itchy, skin rash on arms, sores in mouth, tongue and throat, inside of lower lip swollen and chills. The events resulted in doctor or other healthcare professional office/clinic visit. No therapeutic measures were taken as a result of the events. The clinical outcome of the events chills was passed and skin rash and blisters on back, skin rash on face and forehead that felt like burning and itchy, sores in mouth, tongue and throat, inside of lower lip swollen was ongoing. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1525014
Sex: F
Age:
State: MN

Vax Date: 03/17/2021
Onset Date: 03/18/2021
Rec V Date: 08/04/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Hypotonia, Lethargy, Respiratory rate decreased, Screaming, Skin warm

Symptoms: Began spotting the day after first vaccination.; This is a spontaneous report from a contactable consumer, the patient. A 39-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ED7534) via an unspecified route of administration in the right arm on 17Mar2021 at 14:45 (at the age of 39-year-old) as a single dose for COVID-19 immunisation. The patient had no medical history and had no allergies to food, medications or other products. Concomitant medications included ethinylestradiol, levonorgestrel (LEVONOR/EE TAB 0.15-0.03 91) from unspecified dates for birth control. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 18Mar2021, the patient experienced spotting the day after her first vaccination, which continued for two weeks after receiving the shot. The patient reported that she was on a continuous dosing of birth control pills and she was not supposed to get her period for another seven weeks when the spotting began. She continued to take the birth control pills as prescribed, but still continued to spot for the two weeks after the first shot. The patient did not receive any treatment for the events. The event did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. The clinical outcome of the event spotting was recovered on an unknown date in Apr2021. No follow-up attempts are needed. No further information is expected.

Other Meds: LEVONOR/EE TAB 0.15-0.03 91

Current Illness:

ID: 1525015
Sex: F
Age:
State: OR

Vax Date: 12/22/2020
Onset Date: 01/12/2021
Rec V Date: 08/04/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Vomiting

Symptoms: Severe rash; Weight loss; Fatigue; This is a spontaneous report from a contactable other healthcare professional, the patient. A 39-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: El0k10) via an unspecified route of administration in the right arm on 22Dec2020 at 13:00 (at the age of 39-years-old) as a single dose for COVID-19 immunisation. Medical history included penicillin and sulfa (sulfonamide) allergy. Concomitant medication was not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccination. On 12Jan2021 at 00:00, the patient experienced severe rash, weight loss and fatigue. The events did not result in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. Therapeutic measures were taken as a result of the event severe rash which included treatment with BENADRYL. The clinical outcome of the event's severe rash, weight loss and fatigue were not resolved at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1525016
Sex: F
Age:
State: PA

Vax Date: 03/31/2021
Onset Date: 04/01/2021
Rec V Date: 08/04/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Headache, Limb discomfort, Nasal congestion

Symptoms: headache that evolved into a serious migraine.; woke up with a headache that evolved into aserious migraine; felt nauseous from the pain; This is a spontaneous report from a contactable consumer, the patient. A 34-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: EW9150) via an unspecified route of administration in the left arm on 31Mar2021 at 13:45 (at the age of 34-year-old) as a single dose for COVID-19 immunisation. Medical history included sleep apnea, polycystic ovarian syndrome(PCOS), depression and allergy to red dye #40. Concomitant medications included fexofenadine hydrochloride (ALLEGRA), escitalopram oxalate (LEXAPRO), deogestrel, ethinyl estradiol (VIORELE), lansoprazole (MANUFACTURER UNKNOWN) and vitamin d nos (VITAMIN D), all from unknown dates and for unknown indications. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to COVID-19 vaccination. On 01Apr2021 at 13:00, the patient experienced headache that evolved into a serious migraine, which kept the patient in bed for half the day and also felt nauseous from the pain. The patient did not receive any treatment for the reported events. The adverse events did not result in a visit to the doctors or other healthcare professional office/clinic visit and emergency room/department or urgent care. The clinical outcome of the events headache, migraine and felt nauseous were recovered on an unknown date in Apr2021. No follow-up attempts are needed. No further information is expected.

Other Meds: ALLEGRA; LEXAPRO; VIORELE; Vitamin d; LANSOPRAZOLE

Current Illness:

ID: 1525017
Sex: F
Age:
State: VA

Vax Date: 03/13/2021
Onset Date: 03/19/2021
Rec V Date: 08/04/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Back pain, Cold sweat, Headache, Nausea, Vomiting

Symptoms: POSITIVE SIDE EFFECT one weekafter first dose, my lungs started tofeel better, breathing was easier.; This is a spontaneous report from a contactable consumer. A 44-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6208) via an unspecified route of administration in the arm right on 13Mar2021 at 08:15 (at the age of 44-years-old) as a single dose for COVID-19 immunisation. Medical history included asthma, endometriosis and environmental allergy. Concomitant medications included salbutamol (ALBUTEROL) taken for an unknown indication started from an unknown date. The patient previously took pseudoephedrine (MANUFACTURER UNKNOWN) and experienced drug allergy. The patient was allergic to narcotics. It was unknown whether the patient was diagnosed with COVID-19 prior to the vaccination. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 19Mar2021, the patient experienced POSITIVE SIDE EFFECT one week after first dose, his lungs started to feel better, breathing was easier. The adverse event did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. No therapeutic measures were taken as a result of this event. The clinical outcome of the event unexpected therapeutic benefit was recovered at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: Albuterol

Current Illness:

ID: 1525018
Sex: F
Age:
State: FL

Vax Date: 04/06/2021
Onset Date: 04/06/2021
Rec V Date: 08/04/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Injection site swelling, Limb discomfort

Symptoms: intensity in my stomach that demanded the toilet RIGHT NOW. Barely able to make it to the toilet, the brown rains showered pure liquid for a long while; I noticed I was hot, but then I got chilled to the point I needed a sweater, only to be hot like five minutes after putting it on.; my left arm feeling sore; I have had pins and needles sensation running down my right arm, more towards the pinkie side of my hand and down into my big toe, but mostly in my right arm and hand.; almost like dead weight/I am still having numbness in my right arm and hand.; I have not had much of an appetite after the injection either, which is odd; I had a metallic taste in my mouth that would come and go for the rest of that day; This is a spontaneous report from a contactable other healthcare professional, the patient. A 40-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 06Apr2021 at 14:15 (at the age of 40-years-old) as a single dose for COVID-19 immunisation. Medical history included thyroid, had a bad accident at 19, disc herniation and arthritis, allergies to shellfish and egg whites. Concomitant medications included gabapentin (MANUFACTURER UNKNOWN), loratadine (MANUFACTURER UNKNOWN) and thyroid (ARMOUR THYROID); all on unknown dates for unknown indications. The patient previously received cholestyramine (MANUFACTURER UNKNOWN), mesalamine (PENTASA) and metoclopramide (REGLAN); all on unknown dates for unknown indications and experienced drug allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 06Apr2021 at 14:20, within five minutes, the patient had a metallic taste in her mouth that would come and go for the rest of that day. The next morning, on 07Apr2021, she woke up to her left arm feeling sore, almost like dead weight when she first woke up, but the sensations returned. In her right arm, since the previous day on 07Apr2021 and into day of reporting (today), she have had pins and needles sensation running down her right arm, more towards the pinkie side of her hand and down into her big toe, but mostly in her right arm and hand. This morning on 08Apr2021, when she woke up, she was showering and instantly had to leap from the shower due to an intensity in her stomach that demanded the toilet right away. The patient was barely able to make it to the toilet, and reported 'the brown rains showered pure liquid for a long while'. Once off the toilet, she noticed she was hot, but then she got chilled to the point she needed a sweater, only to be hot like five minutes after putting it on. She had not had much of an appetite after the injection either, which was odd. She was still having numbness in her right arm and hand. The events resulted in doctor or other healthcare professional office/clinic visit. It was unknown if the patient received any treatment for the reported events. The clinical outcome of the events metallic taste, left arm feeling sore, almost like dead weight, pins and needles sensation running down the right arm were recovered with lasting effects on an unknown date on Apr2021 while the events intensity in stomach, she was hot, but then she got chilled to the point she needed a sweater, only to be hot like five minutes after putting it on were recovered with lasting effects on 08Apr2021 and the outcomes of the events loss of appetite and numbness were not recovered at the time of reporting. No follow-up attempts are needed; information about lot/batch number cannot be obtained.

Other Meds: GABAPENTIN; LORATADINE

Current Illness:

ID: 1525019
Sex: F
Age:
State: IN

Vax Date: 04/07/2021
Onset Date: 04/07/2021
Rec V Date: 08/04/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Chills, Diarrhoea, Fatigue, Feeling abnormal, Headache

Symptoms: chills; whole body aches; feet burning; fast heart beat; headache; fatigue; This is a spontaneous report from a contactable consumer, the patient. A 67-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 07Apr2021 at 10:15 (at the age of 67-years-old) as a single dose for COVID-19 immunisation. Medical history included prior to vaccination, the patient was diagnosed with COVID-19, cholesterol, thalassemia and blood pressure high. Concomitant medications included lisinopril(MANUFACTURER UNKNOWN), omeprazole magnesium (OMEPRAZOLE), atorvastatin (MANUFACTURER UNKNOWN) and vitamins(MANUFACTURER UNKNOWN). The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 09Mar2021 at 11:15 as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the vaccination. Since the vaccination, the patient had not been tested for COVID-19. On 07Apr2021 at 20:00, the patient experienced chills, whole body aches, feet burning, fast heartbeat, headache and fatigue. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the occurred events. The clinical outcome of the event chills, whole body aches, feet burning, fast heartbeat, headache and fatigue was recovered on unknown date in Apr2021. No follow-up attempts are needed; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds: LISINOPRIL; OMEPRAZOLE; ATORVASTATIN

Current Illness:

ID: 1525020
Sex: F
Age:
State: NY

Vax Date: 02/16/2021
Onset Date: 03/02/2021
Rec V Date: 08/04/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Hot flush, Myalgia, Nausea, Tension headache

Symptoms: 2 weeks after second dose began experiencing continuous itchiness over most of my body and it still continues today; This is a spontaneous report from a contactable consumer, the patient. A 87-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EL9266,) via an unspecified route of administration in the left arm on 16Feb2021 (at the age of 87-years-old) as a single dose for COVID-19 immunisation. Medical history included blood pressure high (reported as high blood pressure). The patient did not have allergy to any medications, food, or other products. Concomitant medications taken within two weeks prior to the vaccination included lorazepam 1 milligram (MANUFACTURER UNKNOWN) up to four times per day and hydrochlorothiazide 6.25 milligram, bisoprolol fumarate 2.5 milligram (BISOPROLOL FUMARATE & HCTZ) one and a half per day; both from unknown date for unknown indication. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: 59267) via an unspecified route of administration in the left arm on 26Jan2021 at 09:30 (at the age of 87-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 02Mar2021, two weeks after second dose, the patient began experiencing continuous itchiness over most of her body and it still continued on the day of report. The patient reported she had been using the following medications for many years with no side effects: lorazepam 1 milligram up to four times per day., and bisoprololfumarate/ HCTZ tab 2.5/6.25 milligram, one and a half per day. The event resulted in doctor or other healthcare professional office/clinic visit. No therapeutic measures were taken as a result of the event. The clinical outcome of the event two weeks after second dose began experiencing continuous itchiness over most of body and it still continued on the day of report was not resolved at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: LORAZEPAM; BISOPROLOL FUMARATE & HCTZ

Current Illness:

Total 2021 VAERS Injuries: 704,237

Page last modified: 26 October 2021 2:21am